Regulatory

You have access
Biocompatibility Considerations for Orally Inhaled and Nasal Drug Products and Other Drug-–Device Combination Products
Cheryl L. M. Stults, Christine L. Lanning, Lee M. Nagao and James Conners

PDA Journal of Pharmaceutical Science and Technology January 2024, 78 (1) 125-139; DOI: https://doi.org/10.5731/pdajpst.2023.012852
You have access
Using Analytical Platform Technologies to Support Accelerated Product Development—Concept Review and Case Study
Stephan O. Krause

PDA Journal of Pharmaceutical Science and Technology May 2022, 76 (3) 248-262; DOI: https://doi.org/10.5731/pdajpst.2021.012647
You have access
Managing Excipient Supplier Name and Address Changes in the Pharmaceutical Quality System
Richard Rolke, Emma Ramnarine, Anders Vinther and Anil Sawant

PDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 286-288; DOI: https://doi.org/10.5731/pdajpst.2019.011239
You have access
Human Factors Studies for Injectable Combination Products: From Planning to Reporting
John K. Towns

PDA Journal of Pharmaceutical Science and Technology July 2014, 68 (4) 347-361; DOI: https://doi.org/10.5731/pdajpst.2014.00983

Main menu